Process Development

This critical phase of drug manufacturing requires that companies take a scientific approach to process design. Our coverage offers insights on how companies can study and understand every aspect of the manufacturing process to optimize their operations. 

Articles

A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding
Michael Annino/Shutterstock AI
New tools can help seamlessly integrate sustainability into R&D and production goals
Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.
How modern process analytical technologies such as Raman spectroscopy can improve quality control
Shutterstock 2219417471
How the adoption of AI and data-driven techniques can increase efficiencies in pharma manufacturing
Shutterstock 1978782344
The field is in need of more detailed product understanding to increase product safety without sacrificing efficacy
PM2209-HERO-575x327-Development
Research into nanomaterials has opened the door to new therapeutic strategies
PM2209-HERO-575x327-Culture
How reducing technology-addressable vaccine barriers affects coverage rates
engineering
Two key facility considerations that will impact pharma’s business case
PM2208-HERO-575x327-Development
A new biomanufacturing era demands that suppliers and manufacturers partner to efficiently bring new therapies to market
PM2206-HERO-575x327-Development
Comprehensive strategies to save time and reduce cost in end-to-end clinical development
PM2203-HERO-880x500-Development-copy
Overcoming new manufacturing challenges as the cellular immunotherapy landscape expands
PM2202-HERO-575x327-Development-copy
New methods and strategies to address the complexities of viral infection offer hope for antiviral drug development
PM2202-HERO-575x327-Automation-copy
The rapid increase in automated solutions is radically reforming the way scientists discover and develop new therapies
PM2112-HERO-575x327-Operations
How off-the-shelf T-cell platforms can make manufacturing CAR-T therapies more feasible and scalable